Articles Tagged With:
-
Myocarditis, with a Focus on Cases Associated with COVID-19 and Vaccination
This article, will focus on the epidemiology, pathophysiology, presentation, diagnosis, and treatment of acute myocarditis, especially as it relates to SARS-CoV-2 and the COVID-19 mRNA vaccines.
-
Is Cannabis Use a Marker for Atherosclerotic Cardiovascular Disease?
Admitted cannabis use was associated with an increase in the pooled risk of atherosclerosis score in a graded fashion based on the frequency of use, which was consistent across subgroups based on the presence of hypertension, obesity, and hyperlipidemia.
-
How Certain is a Negative Echocardiogram for Excluding Infective Endocarditis?
Applying the proposed strict negative criteria for infective endocarditis (IE) on the first echocardiogram indicated this approach largely prevented unnecessary repeat tests unless clinically indicated for continued suspicion of IE.
-
Does Electrode Position Affect the Results of Cardioversion?
A randomized trial of anteroposterior vs. anterolateral electrode positioning for the biphasic energy cardioversion of atrial fibrillation showed the anterolateral positioning is most effective.
-
Coronary Calcium Score Zero: Are You Home Free?
Among those with a coronary calcium score of 0 after a median follow-up of 16 years, current cigarette smoking, diabetes, and hypertension were independently associated with the development of atherosclerotic cardiovascular disease.
-
CABG Wins Again for Multivessel Disease
In this contemporary trial of revascularization for multivessel disease, fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.
-
U.S. Chlamydia Rates Continue to Climb
The chlamydia infection rate has been rising unabated. While rates of some STIs have fluctuated over the past 40 to 80 years, chlamydia rates have increased progressively since the first reporting data became available in 1984. -
Herpes Vaccine Could Be Available by 2030
Early efforts to produce a protein-based vaccine for herpes failed. But a new mRNA approach has outperformed the efficacy of the past vaccines in preclinical trials and is expected to be introduced in clinical trials in the second half of 2022, investigators say. This new approach for a prophylactic genital herpes vaccine showed great promise in early studies.
-
STI Rates Increasing, but Efficient Testing Can Help
Incidence rates of many sexually transmitted infections (STIs) have increased in the years leading up to the COVID-19 pandemic. There is evidence that STIs have continued to rise during the pandemic, according to the results of a new study. -
Accessing Hormonal Contraception by Pharmacy Prescriptions
A stopgap step to increasing access to hormonal birth control is to expand prescribing authority to pharmacists. Compared to other clinical settings, pharmacies can be easier for people to access, given their wide distribution across the country and their extended hours of operation.